Tag: TAVI
Transverse Medical completes first patient series involving Point-Guard CEP device
Transverse Medical has announced the completion of the first series of patients under its feasibilit...
Post-TAVI pacemaker implantation linked to long-term increase in mortality rates
Pacemaker implantation within 30 days after a transcatheter aortic valve implantation (TAVI) pro...
Early feasibility study of Siegel 8Fr TAVI valve launches
MiRus has announced the launch of the US multicentre early feasibility study (EFS) of the Siegel...
ACC.25: ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation
Data from 500 patients treated for aortic regurgitation with the Trilogy (JenaValve) transcathet...
ACC.25: Evolut Low Risk trial shows comparable rates of all-cause mortality and stroke with TAVI and surgery at five years
Latest data from the Evolut Low Risk trial demonstrate a numerically lower rate of all-cause mor...
CRT 2025: New TAV-in-SAV data underline importance of aortic valve sizing at index procedure
New data on the outcomes of transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) fol...
Protembis names four-person advisory board
Protembis has announced establishment of a scientific advisory board (SAB) to provide objective ...
CRT 2025: Acurate neo2 shows “reassuring” performance in observational study after stuttering IDE trial
Observational data from Sweden’s national registry on coronary and valvular interventions—SWEDEH...
CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial
Two-year results of the SMART trial, comparing two commonly used transcatheter aortic valve impl...
SCAI offers guidance on alternate access for TAVI
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consen...
Caranx Medical makes US FDA submission for AI TAVI guidance software
Caranx Medical has announced that it has made a submission to the US Food and Drug Admnistration...
PCI should be standard of care in patients with coronary artery disease undergoing valve replacement
Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients ...
Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease
The rapid growth of transcatheter aortic valve implantation (TAVI) has been the story of the last tw...
PCR London Valves 2024: New data presented alongside launch of latest-generation Myval device
New analysis of the Myval transcatheter aortic valve implantation (TAVI) system (Meril Life Scie...
ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI
“Disappointed is an understatement,” Michael Reardon (Houston Methodist DeBakey Heart & Vasc...
First patient procedures performed with Abbott’s balloon-expandable TAVI system
Abbott has announced the first patient procedures with its investigational transcatheter aortic ...
PCR London Valves 2024: One-year data affirm clinical performance of Sapien 3 Ultra Resilia TAVI system
One-year data highlighting the performance of the Sapien 3 Ultra Resilia (Edwards Lifesciences) ...
CAPTURE-1 study of EmStop embolic protection system concludes
EmStop has announced the completion of the CAPTURE-1 early feasibility clinical trial assessing the ...
Advertorial: Newest-generation TAVI platforms designed to meet the demands of the modern cath lab
This advertorial is sponsored by Medtronic
As transcatheter aortic valve implantation (TAVI) ...
TCT 2024: New analysis shows difference in rates of stroke among US and non-US cohorts of PROTECTED TAVR trial
New analysis of the PROTECTED TAVR trial has shown a reduction in stroke within the US portion o...
TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis
EARLY TAVR lived up to its billing as one of the most hotly anticipated trials to be presented a...
Medtronic’s Evolut FX+ TAVI system gains CE mark
Medtronic has received CE mark for the Evolut FX+ transcatheter aortic valve implantation (TAVI)...
EMBLOK enrols 50th patient in TAVI embolic protection trial
EMBLOK has announced that it has enrolled the first 50 patients in a clinical trial to evaluate ...
Randomised trial results support pausing anticoagulation prior to TAVI
Patients undergoing transcatheter aortic valve implantation (TAVI) do not benefit from the conti...
ShortCut leaflet splitting device gains US FDA market clearance
The US Food and Drug Administration (FDA) has provided market clearance for the ShortCut (Pi-Car...
AI powered structural heart planning software gains US FDA clearance
Dasi Simulations has announced that its second product—Dasi Dimensions—has earned US Food and Drug A...
First two TAVI procedures completed using Venus-Vitae valve in SMART ALIGN trial
Venus Medtech has announced that its next-generation balloon-expandable dry-tissue transcatheter...
ESC 2024: TAVI “superior” to surgery in women with severe aortic stenosis
The first trial comparing transcatheter aortic valve implantation (TAVI) to surgical aortic valve re...
ESC 2024: AI virtual voice assistant identifies complications after TAVI
Clinical follow-up using virtual voice technology helped identify complications after transcathe...
AI models have potential in heart team decision-making, but beware blindspots
Large language models such as ChatGPT and Google Bard could assist heart teams in decision makin...
Abbott’s Navitor Vision TAVI valve rolled out in UK and Ireland
Abbott is rolling out the latest iteration of its Navitor transcatheter aortic valve implantatio...
NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valves?
Ole De Backer (Copenhagen, Denmark) unpacks the results of the NOTION-2 study, in which investigat...
CardioFlow’s second-generation TAVI system gains CE-MDR certification
MicroPort CardioFlow Medtech Corporation has announced that its self-developed second-generation tra...
First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024
Initial experience with the Siegel (Mirus) 8Fr transcatheter aortic valve implantation (TAVI) de...
Investigators find small reduction in disabling stroke from embolic protection device use
Analysis of data from the TVT registry, looking at the impact of cerebral embolic protection dev...
New York Valves hears five-year data from PARTNER trials focused on small annulus patients
Results of an analysis of data from the PARTNER trials examining outcomes of transcatheter aorti...
EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women
Data from the SMART trial—in which it was shown that a self-expanding transcatheter aortic valve...
EuroPCR 2024: TAVI device with intermediate sizing shown to be non-inferior to contemporary platforms in LANDMARK trial
Early outcomes following the use of a novel balloon-expandable transcatheter aortic valve implan...
EuroPCR 2024: NOTION-2 one-year results prompt questions over TAVI in young, low-risk patients with bicuspid aortic valves
Analysis of one-year results from the NOTION-2 trial, in which investigators compared transcathe...
Edwards’ Sapien 3 Ultra Resilia valve gets European launch
Edwards Lifesciences has announced the European launch of the Sapien 3 Ultra Resilia valve, a tr...
Advertorial: TAVI in small aortic annuli: SMART trial underscores importance of choosing the right device
This advertorial is sponsored by Medtronic
Transcatheter aortic valve implantation (TAVI) has...
Alain Cribier remembered by heavyweights of TAVI
Michael Reardon and Lars Søndergaard pay tribute to the life and legacy of Alain Cribier—the pio...
PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient
Protembis has announced the enrolment of the first patient in the PROTEMBO investigational device ex...
ADVERTORIAL: TAVI offers promise in the “underdiagnosed and undertreated” aortic regurgitation population
This advertorial is sponsored by JenaValve
Transcatheter aortic valve implantation (TAVI) has...
Global registry charts pandemic’s impact on TAVI volumes
Transcatheter aortic valve implantation (TAVI) procedures were more acutely impacted during the ...
BHF PROTECT-TAVI trial poised to answer key questions about use of cerebral embolic protection during TAVI
Investigators behind the largest randomised trial to date to assess the use of cerebral embolic ...
Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment
Genesis MedTech has announced the completion of enrolment in its US early feasibility study (EFS) us...
STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR
Research presented at the 60th annual meeting of the Society of Thoracic Surgeons (STS 2024; 27–...
Chilean centre treats five aortic regurgitation patients in a single day with Zeta TAVI system
Laguna Tech USA has announced that a record number five patients were successfully treated at a sing...
Projected rise in aortic valve-in-valve procedures prompts interest in leaflet splitting device
Details of the first pivotal trial assessing the use of a dedicated leaflet splitting device to ...
Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ
A comparison of two latest-generation self-expanding and balloon-expandable transcatheter aortic...
EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR
A population-based cohort study of patients treated in the Austrian healthcare system has found ...
TAVI operators should master multiple techniques to avoid coronary obstruction
In order to avoid coronary obstruction—a rare but “nasty” complication of transcatheter aortic v...
US FDA approval for AI TAVI planning software
Dasi Simulations has announced it has received US Food and Drug Administration (FDA) clearance for i...
ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI
This advertorial is sponsored by Boston Scientific
Stroke—particularly disabling stroke—is among ...
EuroPCR 2023: FAST-TAVI II highlights benefits of reducing length of stay after TAVI procedures
Implementation of a dedicated training programme allowed hospitals to increase the number of pa...
ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients
This advertorial is sponsored by Boston Scientific
Today there are more than 75,000 transcatheter...
ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients
Three-year results from the Evolut Low Risk trial have shown “durable” benefits of transcatheter...
Five-year durability analysis of CoreValve and Evolut platforms “underscores long-term promise of TAVI”
Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and later-generation Ev...
HOSPITAVI elucidates underlying causes of rehospitalisations among TAVI patients
A single-centre retrospective study of rehospitalisation after transcatheter aortic valve impla...
TAVI pioneers discuss the past, present and future of transcatheter therapy
As transcatheter aortic valve implantation (TAVI) moves beyond its 20-year milestone, two pione...
Transcatheter options for AR open up TAVI to a new patient population
Transcatheter treatment options for aortic regurgitation (AR) bring a new, less invasive approa...
Hospitals without high-level designation more likely to miss strokes following TAVI procedures
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without ...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) transcatheter aortic val...
Cardiovascular News’ top stories of 2022
Which stories, features and interviews captured the attention of the cardiovascular community across...
First US procedure performed using ShortCut leaflet splitting device
Pi-Cardia has announced that the first patient in the USA has been successfully treated with ShortCu...
Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve
The addition of an annular sealing skirt, among other design changes in the Acurate neo2 transca...
Medtronic expands US rollout of Evolut FX TAVI system
Medtronic has announced the expanded US market release of its newest-generation, self-expanding tran...
Key learnings from Manta device study to be presented at TCT
Teleflex has announced that Magnus Settergren, associate professor at the Karolinska Institutet, int...
TAVI will continue to grow, says pioneer of the procedure
Transcatheter aortic valve implantation (TAVI) will continue to spread across the globe as more...
EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI
Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolution of transcatheter...
ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT
Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...
First patient treated in study of PerQseal+ vessel closure device
Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...
CRT 2022: Four-year LRT data “support TAVI in low-risk patients”
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generation of self-expandin...
PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...
Nonagenarians should not be denied TAVI based solely upon age
Nonagenarians should not be refused transcatheter aortic valve implantation (TAVI) based solely upon...
ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI
Edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients wi...
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...
EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients
Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...
SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique
Medtronic has announced results from an interim analysis of the first 171 patients (including 71...
PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findings from the study, d...
Keith Oldroyd to become CMO at Biosensors
Biosensors International Group has announced the appointment of Keith G Oldroyd to the post of c...
Transcatheter heart valves are overlapping with coronary arteries
Data from a pilot imaging study of commissural alignment in trancatheter aortic valve implantati...
TriGUARD 3 given CE mark for embolic protection during TAVI
European CE mark has been awarded to the TriGUARD 3 cerebral embolic protection (CEP) device fro...
ACURATE neo helps facilitate early discharge following TAVI procedures
NOTE: This video is ONLY available to watch in selected countries and geographies
Rajesh ...
CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality
Patients who develop stage 3 acute kidney injury (AKI) following transcatheter aortic valve impl...
Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI
A comparison of newer generation self-expanding valves (SEV) and balloon-expandable valves (BEV)...
STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI
Open heart surgery remains the best option for young and middle-aged adults with aortic valve di...
Selecting the right valve for the patient is key for a successful TAVI program
NOTE: This video is ONLY available to watch in selected countries and geographies
Azeem Latib ...
Low albumin, anaemia, and slow walking speed predict mortality after TAVI
The largest study to date of the role of frailty indices after transcatheter aortic valve implan...
Emboline completes enrolment in SAFEPASS 2 clinical trial
Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emboliner embolic prote...
Self-expanding valves show good haemodynamic performance in small annuli
A retrospective registry comparing four self-expanding transcatheter heart valves has demonstrat...
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results
George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial sess...
PCR London Valves 2019: Meril unveils positive data for Myval
Meril has announced positive data on its Myval Transcatheter Heart Valve System at PCR London Va...
PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI
Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is assoc...
Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients
Patients who have mixed aortic valve disease with pre-existing aortic regurgitation have better ...
Admedus sells CardioCel and VacsuCel to focus on TAVI
Admedus has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 ...
TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route
A subanalysis of PARTNER 3 quality of life data demonstrated a modest, but significant, improvem...
TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems
The Portico IDE study has found that 30-day safety and one-year effectiveness outcomes of a nove...
ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI
Caution: This content is only for readers outside of France and Japan. In the US, ACURATE neo is...
Age alone should not preclude TAVI in patients aged ≥90 years
The clinical frailty score currently used to assess suitability for transcatheter aortic valve i...
SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years
Five-year results suggest that surgical aortic valve replacement (SAVR) is associated with lower...
FEops HEARTguide wins CSI Highlight of the Year Award
FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its FEops HEARTguide unde...
NICE issues recommendations on insertion of cerebral protection devices during TAVI
The National Institute for Health and Care Excellence (NICE) has released evidence-based recommendat...
PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS
Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a...
ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients
Evidence for the use of transcatheter aortic valve replacement (TAVI) as standard therapy is mountin...
Shockwave Intravascular Lithotripsy (IVL) helps facilitate first-choice transfemoral access for TAVR
Carlo Di Mario (Florence, Italy) tells Cardiovascular News at CRT 2019 that there is “incredibl...
SCCT releases new guideline for use of computed tomography in TAVR procedure
The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus doc...
Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification in TAVI patients
According to Anja Stundl (Department of Medicine II, Heart Center Bonn, University Hospital, Bon...
SCAI 2018: 3D model could be used to predict paravalvular leak after TAVI
A new study presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI...
TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients
A review of the trends in the use and propensity-matched analysis of in-hospital outcomes, publi...
“Favourable” in-hospital outcomes for younger patients undergoing TAVI
Registry data for younger patients—under 75 years—undergoing transcatheter aortic valve implanta...
Depression significantly increases mortality after aortic valve replacement
Data from the FRALITY-AVR (Frality aortic valve replacement) study suggest that the presence of ...
Next-day discharge appears safe for TAVI patients without in-hospital complications
Patients who undergo transfemoral transcatheter aortic valve implantation (TAVI) with a minimali...
Modifying procedural technique during TAVI may lower radiation exposure to patients
Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Center, Omaha, USA) and...
Claret Medical closes on series C financing of US$14.5m
Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Light...
Relatively few chronic kidney disease patients require dialysis after TAVI
James W Hansen (Lahey Hospital and Medical Center, Burlington, USA) and others report in JACC: C...
No significant differences in post TAVI outcomes between African Americans and Caucasians
Fahad Alqahtani (Division of Cardiology, West Virginia University Heart & Vascular Institute...
All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device
Jochen Wöhrle (Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany) ...
ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event
Of 5,691 adverse events following transcatheter aortic valve implantation (TAVI) that were repor...
ProtEmbo cerebral protection system used for first time
The ProtEmbo cerebral protection system (Protembis) has been used, to complement a transcatheter...
CE mark for CoreValve Evolut Pro
Medtronic has received the CE mark for its CoreValve Evolut Pro valve for the treatment of sever...
EuroPCR 2017: A “golden era” for valve disease therapies
At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure o...
Embolic protection device company raises US$5million in series B financing for advanced device development and initiation of US clinical activities
Innovative Cardiovascular Solutions has announced today completion of an oversubscribed Series B...
CoreValve Evolut can be used to treat intermediate-risk patients in the USA
Medtronic has announced that the FDA has approved the company’s self-expanding transcatheter aor...
Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients
Jonathan Afilalo (Division of Cardiology, Jewish General Hospital, McGill University, Montreal, ...
Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates
Researchers at Georgia Institute of Technology and the Piedmont Heart Institute (both Atlanta, USA) ...
Nearly one in 10 US TAVI procedures is off label but results seem acceptable
Ravi S Hira (Section of Cardiology, University of Washington, Seattle, USA) and others report in...
EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices
New data presented, by Luca Testa (Department of Cardiology, IRCCS Policlinico S. Donato, Milan,...
Study confirms that volume matters for achieving lower in-hospital mortality after TAVI
A study, published in EuroIntervention, provides further evidence that there is an inverse relat...
Bicuspid aortic stenosis: TAVI’s next challenge
Most of the initial registries, and the large randomised trials, for transcatheter aortic valve ...
EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI
The ARTE study, which was simultaneously presented at EuroPCR (16–19 May, Paris, France) and pub...
TVT 2017: Presentation showcases safety of Tempo temporary pacing lead
BioTrace Medical announced that its Tempo temporary pacing lead was featured in an oral presenta...
US centres of TAVI excellence start to use newly approved Sentinel device
Claret Medical has announced that several of the largest centres of excellence for transcatheter...
HLT’s TAVI system implanted in first US patients
The first patients in an early feasibility study of HLT’s transcatheter aortic valve implantation (T...
TVT 2017: “I predict a very exciting and bright future” for transcatheter valve therapies
This year marks the 10th anniversary of the Transcatheter Valve Therapies (TVT) meeting (14–17 J...
Sentinel becomes first cerebral protection device to receive FDA approval
Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protecti...
EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve
According to late-breaking trial presented at EuroPCR (16–19 May, Paris, France), a novel self-e...
EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year
Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAV...
Boston Scientific closes Symetis acquisition
Boston Scientific Corporation has announced the close of its acquisition of Symetis SA, a privat...
The role of nurses in ensuring a patient-focused TAVI service
Preadmission clinics for patients awaiting elective procedures or surgery are not a new concept....
Reduced baseline left ventricular function may explain female survival benefit after TAVI
A new study indicates that the apparent survival benefit after transcatheter aortic valve implan...
Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in atrial fibrillation undergoing TAVI
The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on...
Meta-analysis supports transaortic approach in TAVI
A meta-analysis of single-centre studies indicates that the use of the transaortic appraoch in p...
First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study
HLT has announced that the first patient implants in a feasibility clinical study to assess the safe...
CE mark granted to NVT for Allegra transcatheter aortic valve
NVT has received the CE mark for its Allegra transcatheter aortic valve, which it describes as “...
Boston Scientific agrees to acquire Symetis
Boston Scientific Corporation have definitively agreed to acquire Symetis, a privately-held Swiss st...
TAVI pacemaker issue is “an engineering problem that will be solved”
The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI) with CoreValve/...
ACC 2017: FDA approves launch of CoreValve Evolut Pro
The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (T...
ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarte...
TAVI may benefit certain heart valve patients, update society guidelines say
New recommendations have been published by the American Heart Association and the American College o...
ACC 2017: No significant differences in two-year morality between bicuspid and tricuspid aortic stenosis patients undergoing TAVI
Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal ...
ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients
Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessi...
Innovative Cardiovascular Solutions announces successful first use of its Emblok embolic protection system
Innovative Cardiovascular Solutions has announced the successful first European clinic...
Early hospital discharge after TAVI less likely in women
A study, published in the Journal of Interventional Cardiology, indicates that females, bleeding...
Valve replacement may better than vavluloplasty for aortic stenosis patients with end-stage renal disease
A new study published in Catheterization and Cardiovascular Interventions indicates that valve r...
FDA advisory panel recommend de novo approval of Sentinel cerebral protection system
In an open public hearing of the FDA’s circulatory system devices panel, according to a press re...
Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device
According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valv...
New guidelines released to improve stroke reporting following cardiac procedures
In response to a growing body of evidence of the existence of "covert" brain injury to patients ...
Meta-analysis indicates embolic protection does reduce stroke after TAVI
In a research letter published in the Journal of the American College of Cardiology, Gennaro Giu...
Positive results for heart surgery in elderly aortic stenosis patients
Elderly patients with aortic stenosis and medium surgical risk experienced better than expected resu...
Left atrial appendage thrombus may increase the risk of stroke after TAVI
Sonny Palmer (St Vincent’s Hospital, Melbourne, Australia) and others report in JACC: Cardiovasc...
Medtronic receives CE mark for 34mm size CoreValve Evolut R
The CE mark has been granted to Medtronic for the 34mm-valve version of its CoreValve Evolut R, ...
TAVI company Direct Flow Medical closes after failing to secure funding
Direct Flow Medical, which markets a CE-marked transcatheter aortic valve implantation (TAVI) device...
The management of leaflet thickening after TAVI remains controversial
Ryo Yanagisawa (Department of Cardiology, Keio University School of Medicine, Tokyo, Japan) and ...
New AHA/ACC guidance released for TAVI
A new expert consensus decision pathway will assist clinicians and hospitals in assessing patients’ ...
Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis
Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: ...
Women fare better than men one year after transcatheter aortic valve implantation
Women with significant aortic valve disease who undergo transcatheter aortic valve implantation ...
Minimally invasive TAVI has “several potential benefits”
Recently, there has been a move towards transcatheter aortic valve implantation (TAVI) procedure...
Pacemaker after TAVI is associated with worse outcomes
A study in JACC: Cardiovascular Interventions indicates that patients who require a pacemaker after ...
NICE should develop heart valve guidelines says Heart Valve Voice
UK charity Heart Valve Voice has launched a report—Towards a Heart Healthy Future: a 2020 Vision for...
TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model
The SENTINEL trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (T...
TCT 2016: Positive real-world data for CoreValve Evolut R presented
Today, Medtronic presented new positive data from two large registries aimed at evaluating 30-da...
FDA clear temporary pacing lead for use during TAVI and other cardiovascular applications
BioTrace Medical has received FDA 510(k) clearance for its Tempo Lead, which a press release des...
TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients
Anna Franzone (Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern,...
TAVI at the end of life: Knowing when it is futile
Understanding how aggressively to treat patients in their last years of life is challenging for ...
Simplified TAVI device may benefit patients with rheumatic heart disease
At the South Africa Heart Association annual congress (8–11 September, Cape Town, South Africa),...
PCRLV 2016: New approaches to TAVI are still being explored
Although much of the innovation in transcatheter solutions for structural heart disease is now f...
TriGuard cerebral protection associated with significant improvements in brain protection in TAVI patients
Preliminary real-world findings, presented at PCR London Valves (18–20 September, London, UK), i...
Claret Medical submits application for FDA approval of its cerebral protection device
Claret Medical has announced its filing of a marketing application with the FDA for clearance of...
Sapien 3 now approved for intermediate-risk patients in Europe as well as in the USA
Following last month’s FDA approval for the expanded indication of Sapien 3 for the treatment of...
PCRLV 2016: Next-generation of Lotus TAVI receives CE mark
Coinciding with PCR London Valves (18-20 September, London, UK), Boston Scientific has announced...
TCT 2016: Pivotal trial on cerebral protection device to be presented as a late-breaker
Data from the SENTINEL pivotal IDE trial will be presented during a late-breaking trial session ...
Redo TAVI procedures are safe and feasible
Marco Barbanti (Ferrarotto Hospital, University of Catania, Catania, Italy) and others report in...
“Keep it fast and simple” to avoid periprocedural stroke after TAVI
At PCR London Valves (18–20 September, London, UK), Holger Eggebrecht (Cardioangiological Center...
Vivasure Medical secures €16.2 million series C financing
Vivasure Medical has announced that the company has completed a series C financing of €16.2 million....
Edwards Sapien 3 granted expanded indication from US FDA
Edwards Lifesciences has announced US Food and Drug Administration (FDA) approval to expand use ...
CE mark granted to InSeal Medical for InClosure vascular closure device
InSeal Medical has received CE mark approval for its InClosure VCD; a large bore vascular closur...
Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.
Boston Scientific has sent a letter to its customers notifying them that it is implementing a “v...
Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients
Medtronic has received CE marking for the self-expanding, recapturable and repositionable CoreValv...
What is required for TAVI to become the new gold standard?
Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) ha...
TAVI with Sapien 3 may be better than surgery for intermediate-risk patients
A
ccording to Vinod H Thourani (Emory University School of Medicine, Atlanta, USA...
Moderate sedation during TAVI associated with significantly better outcomes
Jay Giri (Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Phil...
